These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 16723570)

  • 1. Targeting antibacterial agents by using drug-carrying filamentous bacteriophages.
    Yacoby I; Shamis M; Bar H; Shabat D; Benhar I
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2087-97. PubMed ID: 16723570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted drug-carrying bacteriophages as antibacterial nanomedicines.
    Yacoby I; Bar H; Benhar I
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2156-63. PubMed ID: 17404004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibacterial application of engineered bacteriophage nanomedicines: antibody-targeted, chloramphenicol prodrug loaded bacteriophages for inhibiting the growth of Staphylococcus aureus bacteria.
    Vaks L; Benhar I
    Methods Mol Biol; 2011; 726():187-206. PubMed ID: 21424451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted filamentous bacteriophages as therapeutic agents.
    Yacoby I; Benhar I
    Expert Opin Drug Deliv; 2008 Mar; 5(3):321-9. PubMed ID: 18318653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Back to the future: bacteriophages as promising therapeutic tools.
    Domingo-Calap P; Georgel P; Bahram S
    HLA; 2016 Mar; 87(3):133-40. PubMed ID: 26891965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo characteristics of targeted drug-carrying filamentous bacteriophage nanomedicines.
    Vaks L; Benhar I
    J Nanobiotechnology; 2011 Dec; 9():58. PubMed ID: 22185583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Killing cancer cells by targeted drug-carrying phage nanomedicines.
    Bar H; Yacoby I; Benhar I
    BMC Biotechnol; 2008 Apr; 8():37. PubMed ID: 18387177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phage-Derived Antibacterials: Harnessing the Simplicity, Plasticity, and Diversity of Phages.
    Kim BO; Kim ES; Yoo YJ; Bae HW; Chung IY; Cho YH
    Viruses; 2019 Mar; 11(3):. PubMed ID: 30889807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drugs against superbugs: private lessons from bacteriophages.
    Brown ED
    Trends Biotechnol; 2004 Sep; 22(9):434-6. PubMed ID: 15331220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fighting Pathogenic Bacteria on Two Fronts: Phages and Antibiotics as Combined Strategy.
    Tagliaferri TL; Jansen M; Horz HP
    Front Cell Infect Microbiol; 2019; 9():22. PubMed ID: 30834237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The fascinating biology behind phage display: filamentous phage assembly.
    Loh B; Kuhn A; Leptihn S
    Mol Microbiol; 2019 May; 111(5):1132-1138. PubMed ID: 30556628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress towards a stable cephalosporin-halogenated phenazine conjugate for antibacterial prodrug applications.
    Xiao T; Liu K; Huigens RW
    Bioorg Med Chem Lett; 2020 Nov; 30(22):127515. PubMed ID: 32860978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug delivery vectors based on filamentous bacteriophages and phage-mimetic nanoparticles.
    Ju Z; Sun W
    Drug Deliv; 2017 Nov; 24(1):1898-1908. PubMed ID: 29191048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phages and their potential to modulate the microbiome and immunity.
    Federici S; Nobs SP; Elinav E
    Cell Mol Immunol; 2021 Apr; 18(4):889-904. PubMed ID: 32901128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacteriophages: potential treatment for bacterial infections.
    Duckworth DH; Gulig PA
    BioDrugs; 2002; 16(1):57-62. PubMed ID: 11909002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacteriophages: A Therapy Concept against Multi-Drug-Resistant Bacteria.
    Rohde C; Wittmann J; Kutter E
    Surg Infect (Larchmt); 2018; 19(8):737-744. PubMed ID: 30256176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [System analysis of the ecological distribution of bacteriophages in hospital wastewater].
    Lu JY; Pan HW; Sun EH; Li W; Wang HX; Zhao XL; Wang HC
    Zhonghua Yu Fang Yi Xue Za Zhi; 2024 Feb; 58(2):241-247. PubMed ID: 38387957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ofloxacin@Doxorubicin-Epirubicin functionalized MCM-41 mesoporous silica-based nanocarriers as synergistic drug delivery tools for cancer related bacterial infections.
    Galhano J; Marcelo GA; Duarte MP; Oliveira E
    Bioorg Chem; 2022 Jan; 118():105470. PubMed ID: 34814085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial drug discovery through bacteriophage genomics.
    Liu J; Dehbi M; Moeck G; Arhin F; Bauda P; Bergeron D; Callejo M; Ferretti V; Ha N; Kwan T; McCarty J; Srikumar R; Williams D; Wu JJ; Gros P; Pelletier J; DuBow M
    Nat Biotechnol; 2004 Feb; 22(2):185-91. PubMed ID: 14716317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacteriophages: The promising therapeutic approach for enhancing ciprofloxacin efficacy against bacterial infection.
    Shariati A; Noei M; Chegini Z
    J Clin Lab Anal; 2023 May; 37(9-10):e24932. PubMed ID: 37377167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.